PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10695015-7	1999	Treatment of human colorectal carcinoma SW-620 cells with sodium butyrate(NaB) induced LRP in the cells and conferred resistance to Adrianycin(ADM), VCR, VP-16, gramicidin D and taxol.	nab	74-77	major vault protein	Homo sapiens	87-90	
10695015-8	1999	Two LRP-specific ribozymes inhibited the NaB-induced expression of LRP in SW-620 cells and almost completely abolished their acquisition of the MDR phenotype.	nab	41-44	major vault protein	Homo sapiens	4-7	
10695015-8	1999	Two LRP-specific ribozymes inhibited the NaB-induced expression of LRP in SW-620 cells and almost completely abolished their acquisition of the MDR phenotype.	nab	41-44	major vault protein	Homo sapiens	67-70	
10695015-12	1999	Efflux of ADM from nuclei isolated from NaB-treated cells was enhanced compared with those from untreated cells and NaB-treated cells transfected with a LRP-specific ribozyme.	nab	40-43	major vault protein	Homo sapiens	153-156	
10695015-12	1999	Efflux of ADM from nuclei isolated from NaB-treated cells was enhanced compared with those from untreated cells and NaB-treated cells transfected with a LRP-specific ribozyme.	nab	116-119	major vault protein	Homo sapiens	153-156	
10695015-13	1999	The polyclonal antibody against LRP inhibited the enhanced efflux of ADM from nuclei isolated from NaB-treated cells.	nab	99-102	major vault protein	Homo sapiens	32-35